Publicacions (16) Publicacions de REBECA BURGOS PANADERO

2024

  1. MET TL3 drives telomere targ eting of TERRA lncRNA through m 6 A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

    Nucleic Acids Research, Vol. 52, Núm. 5, pp. 2648-2671

  2. The prognostic relevance of a gene expression signature in MRI-defined highly vascularized glioblastoma

    Heliyon, Vol. 10, Núm. 11

2023

  1. Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma

    Computers in Biology and Medicine, Vol. 164

  2. Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants

    Genome Research, Vol. 33, Núm. 3, pp. 299-313

2021

  1. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608

2020

  1. A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior

    Scientific Reports, Vol. 10, Núm. 1

  2. An integral view of cancer (III). Evaluation of new biomarkers and treatment strategies

    Revista Espanola de Patologia, Vol. 53, Núm. 2, pp. 88-99

  3. Digital image analysis applied to tumor cell proliferation, aggressiveness, and migration-related protein synthesis in neuroblastoma 3d models

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-17

  4. Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

    Journal of Experimental and Clinical Cancer Research, Vol. 39, Núm. 1

  5. Integrating the tumor microenvironment into cancer therapy

    Cancers, Vol. 12, Núm. 6, pp. 1-24

  6. The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 553-565

2019

  1. An integral view of cancer (I). The study, classification and reprogramming of the tumoral microclimate

    Revista Espanola de Patologia, Vol. 52, Núm. 2, pp. 92-102

  2. An integral view of cancer (II). Fields of investigation and emerging biomarkers

    Revista Espanola de Patologia, Vol. 52, Núm. 4, pp. 222-233

  3. High Oct4 expression: Implications in the pathogenesis of neuroblastic tumours

    BMC Cancer, Vol. 19, Núm. 1

  4. The tumour microenvironment as an integrated framework to understand cancer biology

    Cancer Letters

  5. Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma

    BMC Cancer, Vol. 19, Núm. 1